Intensive Care Med. 2013 Dec;39(12):2115-25. doi: 10.1007/s00134-013-3074-x.
To analyze the frequency, rationale and determinants of attending physicians requesting that their eligible patients not be approached for participation in a thromboprophylaxis trial.
Research personnel in 67 centers prospectively documented eligible non-randomized patients due to physicians declining to allow their patients to be approached.
In 67 centers, 3,764 patients were enrolled, but 1,460 eligible patients had no consent encounter. For 218 (14.9 %) of these, attending physicians requested that their patients not be approached. The most common reasons included a high risk of bleeding (31.2 %) related to fear of heparin bioaccumulation in renal failure, the presence of an epidural catheter, peri-operative status or other factors; specific preferences for thromboprophylaxis (12.4 %); morbid obesity (9.6 %); uncertain prognosis (6.4 %); general discomfort with research (3.7 %) and unclear reasons (17.0 %). Physicians were more likely to decline when approached by less experienced research personnel; considering those with[10 years of experience as the reference category, the odds ratios (OR) for physician refusals to personnel without trial experience was 10.47 [95 % confidence interval (CI) 2.19-50.02] and those with less than 10 years experience was 1.72 (95 % CI 0.61-4.84). Physicians in open rather than closed units were more likely to decline (OR 4.26; 95 % CI 1.27-14.34). Refusals decreased each year of enrollment compared to the pilot phase.
Tracking, analyzing, interpreting and reporting the rates and reasons for physicians declining to allow their patients to be approached for enrollment provides insights into clinicians' concerns and attitudes to trials. This information can encourage physician communication and education, and potentially enhance efficient recruitment.
分析主治医生要求其符合条件的患者不参与血栓预防试验的频率、理由和决定因素。
67 个中心的研究人员前瞻性地记录了因医生拒绝允许患者参与而不符合随机分组条件的合格患者。
在 67 个中心,共纳入 3764 名患者,但 1460 名符合条件的患者未进行同意访谈。对于其中 218 名(14.9%)患者,主治医生要求不接触他们的患者。最常见的原因包括因担心肝素在肾衰竭中的生物蓄积而导致出血风险高(31.2%),存在硬膜外导管、围手术期状态或其他因素;对血栓预防的特殊偏好(12.4%);病态肥胖(9.6%);预后不确定(6.4%);对研究的一般不适(3.7%)和原因不明(17.0%)。当研究人员经验不足时,医生更有可能拒绝;与[10 年经验的医生相比,无试验经验的医生拒绝率的比值比(OR)为 10.47(95%置信区间(CI)为 2.19-50.02),经验不足 10 年的医生为 1.72(95%CI 为 0.61-4.84)。与封闭式病房相比,开放式病房的医生更有可能拒绝(OR 4.26;95%CI 1.27-14.34)。与试点阶段相比,每年的入组人数都有所减少。
跟踪、分析、解释和报告医生拒绝允许其患者参与招募的比例和原因,可深入了解临床医生对试验的关注和态度。这些信息可以鼓励医生之间的沟通和教育,并有可能提高招募效率。